The global laboratory centrifuges market is projected to USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026. The growth of this market is driven by increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges. Also, Integration of automation and advanced features in laboratory centrifuges and emerging economies are anticipated to offeropportunity for the growth of the market during the forecast period.
Equipment are expected to hold the largest share of the laboratory centrifuges market, by product in 2021. Based on product, the laboratory centrifuges market is segmented into equipment and accessories.In 2020, the equipment segment accounted for the largest share of the laboratory centrifuges market.
The large share of the equipment segment can be attributed to the requirement of the repeated purchase of accessories such as tubes, bottles, and buckets.
Benchtop centrifuges are expected to hold the largest share of the laboratory centrifuges market, by model type in 2021. Based on model type, the laboratory centrifuges market is segmented into benchtop and floor-standing centrifuges.Among these, the benchtop centrifuges segment accounted for the larger market share since these centrifuges are cost-effective, versatile, easy to use, smaller in size, and considerably lighter in weight.
These advantages have resulted in their increased adoption in the laboratory centrifuges market.
General purpose centrifuges are expected to hold the largest share of the laboratory centrifuges market, by intended use in 2021. Based on intended use, the laboratory centrifuges market is segmented into clinical, preclinical, and general purpose centrifuges. The general purpose centrifuges segment accounted for the largest market share in 2020, owing to an increase in cellular research and the diagnosis of blood-related diseases are the major factors driving the growth of this market.
Fixed-angle rotors are expected to hold the largest share of the laboratory centrifuges market, by rotor design in 2021. Based on rotor design, the laboratory centrifuges market is segmented into swinging-bucket rotors, fixed-angle rotors, vertical rotors, and other rotors based on rotor design.The fixed-angle rotors segment accounted for the largest share in the laboratory centrifuge equipment market in 2020.
Factors such as increasing protein research activities and advantages associated with fixed-angle rotors such as fast runtime and excellent resolution are driving the growth of this market.
Diagnostics segment are expected to hold the largest share of the laboratory centrifuges market, by application in 2021. Based on application, the laboratory centrifuges market is segmented into diagnostics, microbiology, cellomics, genomics, proteomics, blood component separation, and other applications (biochemical analysis and nanotechnology research). In 2020, the diagnostics segment accounted for the largest share of the laboratory centrifuges market, owing to the rising prevalence of various diseases and the focus on ensuring early disease diagnosis are the major factors driving the growth of the laboratory centrifuges market for this application segment.
Hospitals are expected to hold the largest share of the laboratory centrifuges market, by end user in 2021. Based on end user, the laboratory centrifuges market is segmented into hospitals, biotechnology & pharmaceutical companies, and academic & research institutes.The hospitals segment accounted for the largest share in the laboratory centrifuges market in 2020.
The increasing prevalence of diseases, coupled with the growing awareness regarding early diagnosis & treatment, increasing demand for blood, availability of novel and technologically advanced centrifuges for blood separation, and growing number of hospitals, especially in emerging countries, are some of the key factors driving the growth of the laboratory centrifuges market for hospitals.
North America commanded the largest share of the laboratory centrifuges market in 2021. Based on region, the laboratory centrifuges market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW).In 2020, North America commanded the largest share of the laboratory centrifuges market.
The large share of North America can be attributed to the rising R&D investments by government bodies, increasing emphasis on better management and the treatment of infectious diseases, and rapid growth in the pharmaceutical industry.
Breakdown of supply-side primary interviews, by company type, designation, and region: • By Company Type: Tier 1 (38%), Tier 2(48%), and Tier 3 (16%) • By Designation: C-level Executives (29%), Directors (43%), and Others (28%) • By Region: North America (42%), Europe (24%), AsiaPacific(19%), and Rest of the World (RoW) (15%).
Some of the major players operating in this market areThermo Fisher Scientific, Inc(US), Danaher Corporation(US), and Eppendorf AG (Germany)
List of Companies Profiled in the Report • Thermo Fisher Scientific, Inc. (US) • Danaher Corporation (US) • Eppendorf AG (Germany) • KUBOTA Corporation (Japan) • Sigma Laborzentrifugen GmbH (Germany) • Andreas Hettich GmbH & Co. KG (Germany) • NuAire (US) • QIAGEN N.V. (Netherlands) • Sartorius AG (Germany) • HERMLE Labortechnik GmbH (Germany) • Cardinal Health (US) • Centurion Scientific (UK) • Bio-Rad Laboratories, Inc. (US) • Agilent Technologies (US) • Haier Biomedical (China) • Antylia Scientific • Heal Force (China) • Benchmark Scientific (US) • VISION Scientific, Co., Ltd. (Korea) • Meditech Technologies India Private Limited (India) • Laby Instruments Industry (India) • Kay & Company (India) • Narang Medical Limited (India) • REMI GROUP (India)
Research Coverage This report studies the laboratory centrifuges market based on product, rotor design, model type, intended use, application, end user, and region.The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.
It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total laboratory centrifuges market.
The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers: • Market Penetration: Comprehensive information on laboratory centrifugesoffered by the top 24 players in the laboratory centrifuges market. The report analyzes the laboratory centrifuges marketproduct, rotor design, model type, intended use, application, end user,and region. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the laboratory centrifuges market • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the laboratory centrifuges market
Our reports have been used by over 10K customers, including:
The global IVD contract research organization market is expected to grow from US$ 4,738.79 million in 2021 to US$ 8,019.53 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028. The rising prevalence of infectious diseases increases the demand for IVD and clinical trials along with new product launches, which...
The in vitro diagnostics market was valued at approximately USD 76,281.75 million in 2021, and it is expected to witness a revenue of USD 1,01,542.35 million in 2027, with a CAGR of 4.90% over the forecast period. The COVID-19 pandemic turned the spotlight on in vitro diagnostics since there is an increasing demand for IVD kits and...
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...
The global in-vitro diagnostics market was valued at approximately USD 68,410 million in 2020, and it is expected to witness a revenue of USD 91,250 million in 2026, with a CAGR of 4.90% over the forecast period. The COVID-19 pandemic turned the spotlight on in-vitro diagnostics, since there is an increasing demand for the IVD kits...
The global IVD quality control market is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period. IVD testing plays a significant role in clinical decision-making. The growth of the IVD quality control market is primarily driven by the rising number of accredited clinical laboratories,...
198 pages •
By Asia Market Information & Development Company
• Aug 2021
China’s demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
Saudi Arabia In-Vitro Diagnostics (IVD) market is predicted to reach US$ 1,242 Million by 2027. Saudi Arabia is the largest IVD market in the GCC region. As in other countries, Saudi Arabia is facing the challenges of fighting with infectious disease including HBV, TB, HCV, COVID-19 and HIV, as well as various chronic disease and cancer. In-vitro...
The in-vitro diagnostics market in North America is expected to grow from US$ 26,981.2 million in 2019 to US$ 38,759.6 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. For instance, according to the research conducted by American...
The in-vitro diagnostics market in Europe is expected to grow from US$ 15,973.0 million in 2019 to US$ 22,221.8 million by 2027; it is estimated to grow at a CAGR of 4.2% from 2020 to 2027. The in-vitro diagnostics market has accounted for a significant market share in the healthcare industry during the COVID-19 pandemic. The market growth...
The in-vitro diagnostics market in Asia Pacific is expected to grow from US$ 13,729.8 million in 2019 to US$ 20,401.5 million by 2027; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. Incidence of chronic diseases such as cancers, chronic respiratory diseases, diabetes, and heart disease is growing due to biological risk factors,...
In Vitro Diagnostics
APAC
Cancer Incidence
Chronic Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.
